BibTex RIS Cite
Year 2016, Volume: 2 Issue: 1, 0 - 0, 27.03.2016

Abstract

References

  • Burn DJ, Lees AJ. Progressive supra nuclearpalsy: where are we now? Lancet Neurology 2002; 1: 359–69.
  • Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuro pathologic criteria for Steele–Richardson–Olszewskisyndrome (progressive supranuclear palsy). Neurology 1994; 44: 2015–19.
  • Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuro pathologic criteria for progressive supranuclear palsy and relateddisorders. J Neuropathol Exp Neurol 1996; 55: 97–105. 4. Brusa A, Mancardi GL, Bugiani O. Progressive supranuclear palsy. Ital J NeurolSci 1980; 4: 205–22.
  • Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1–9.
  • Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988; 38: 1031–34.
  • Nath U, Ben-Shlomo Y, Thomson RG, et al. Clinicalfeatures of progressive supranuclear palsy (PSP) in the United Kingdom. Neurology2001; 56 (suppl 3): A458.
  • Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain 2005; 128: 1247–58.
  • Kaat LD, Boon AJ, Kamphorst W, Ravid R, Duivenvoorden HJ, van Swieten JC. Frontal presentation in progressive supranuclear palsy. Neurology 2007; 69: 723–29.
  • Williams DR, Lees AJ. How do patients with Parkinsonism present? A clinico pathological study. Internal Medicine Journa l2008; published online April 16.

Progresif Supranükleer Palsi: İki Olgu Sunumu

Year 2016, Volume: 2 Issue: 1, 0 - 0, 27.03.2016

Abstract

Progresif supranükleer palsi (PSP) oftalmopleji, psödobulber paralizi, bradikinezi ve rijidite gibi parkinsoniyen semptomların yanında, davranışsal ve bilişsel bulgularında eşlik ettiği bir hastalıktır. PSP diğer hareket bozuklukları karışabilmekte ve sıklıkla yanlış tanı almaktadır. 61 yaşında parkinsonizm şikayetleri olmasına rağmen vertigo tanısı alan ve 63 yaşında idiyopatik parkinson hastalığı tanısı almış iki adet erkek PSP olgusu sunuldu. Parkinsonizm bulguları gösteren hastalarda PSP açısından özellikle erken düşme, simetrik bulgular, kognitif bozulma varlığına dikkat edilmeli ve verilen tedaviye klinik cevap gözlenmelidir. Bu yazıda klinisyenlerin PSP olgularına farkındalığını arttırmayı amaçladık.

Anahtar Kelimeler: Progresif supranükleer palsi, parkinsonizm, penguen görünümü

References

  • Burn DJ, Lees AJ. Progressive supra nuclearpalsy: where are we now? Lancet Neurology 2002; 1: 359–69.
  • Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuro pathologic criteria for Steele–Richardson–Olszewskisyndrome (progressive supranuclear palsy). Neurology 1994; 44: 2015–19.
  • Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuro pathologic criteria for progressive supranuclear palsy and relateddisorders. J Neuropathol Exp Neurol 1996; 55: 97–105. 4. Brusa A, Mancardi GL, Bugiani O. Progressive supranuclear palsy. Ital J NeurolSci 1980; 4: 205–22.
  • Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1–9.
  • Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988; 38: 1031–34.
  • Nath U, Ben-Shlomo Y, Thomson RG, et al. Clinicalfeatures of progressive supranuclear palsy (PSP) in the United Kingdom. Neurology2001; 56 (suppl 3): A458.
  • Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain 2005; 128: 1247–58.
  • Kaat LD, Boon AJ, Kamphorst W, Ravid R, Duivenvoorden HJ, van Swieten JC. Frontal presentation in progressive supranuclear palsy. Neurology 2007; 69: 723–29.
  • Williams DR, Lees AJ. How do patients with Parkinsonism present? A clinico pathological study. Internal Medicine Journa l2008; published online April 16.
There are 9 citations in total.

Details

Journal Section Articles
Authors

Bekir Enes Demiryürek This is me

MUSTAFA Ceykan This is me

BİLGEHAN ATILGAN Acar This is me

AYBALA NESLİHAN Alagöz This is me

Esra Demiryürek This is me

Publication Date March 27, 2016
Submission Date March 27, 2016
Published in Issue Year 2016 Volume: 2 Issue: 1

Cite

APA Demiryürek, B. E., Ceykan, M., Acar, B. A., Alagöz, A. N., et al. (2016). Progresif Supranükleer Palsi: İki Olgu Sunumu. Journal of Human Rhythm, 2(1).
AMA Demiryürek BE, Ceykan M, Acar BA, Alagöz AN, Demiryürek E. Progresif Supranükleer Palsi: İki Olgu Sunumu. Journal of Human Rhythm. March 2016;2(1).
Chicago Demiryürek, Bekir Enes, MUSTAFA Ceykan, BİLGEHAN ATILGAN Acar, AYBALA NESLİHAN Alagöz, and Esra Demiryürek. “Progresif Supranükleer Palsi: İki Olgu Sunumu”. Journal of Human Rhythm 2, no. 1 (March 2016).
EndNote Demiryürek BE, Ceykan M, Acar BA, Alagöz AN, Demiryürek E (March 1, 2016) Progresif Supranükleer Palsi: İki Olgu Sunumu. Journal of Human Rhythm 2 1
IEEE B. E. Demiryürek, M. Ceykan, B. A. Acar, A. N. Alagöz, and E. Demiryürek, “Progresif Supranükleer Palsi: İki Olgu Sunumu”, Journal of Human Rhythm, vol. 2, no. 1, 2016.
ISNAD Demiryürek, Bekir Enes et al. “Progresif Supranükleer Palsi: İki Olgu Sunumu”. Journal of Human Rhythm 2/1 (March 2016).
JAMA Demiryürek BE, Ceykan M, Acar BA, Alagöz AN, Demiryürek E. Progresif Supranükleer Palsi: İki Olgu Sunumu. Journal of Human Rhythm. 2016;2.
MLA Demiryürek, Bekir Enes et al. “Progresif Supranükleer Palsi: İki Olgu Sunumu”. Journal of Human Rhythm, vol. 2, no. 1, 2016.
Vancouver Demiryürek BE, Ceykan M, Acar BA, Alagöz AN, Demiryürek E. Progresif Supranükleer Palsi: İki Olgu Sunumu. Journal of Human Rhythm. 2016;2(1).